AHA 2021: Late-breaking Science Video Collection
Published: 12 November 2021
-
Views:
4053
-
Likes:
7
-
Views:
4053
-
Likes:
7
-
16m 38sPart 1 | Session 1 AHA 2021 Late-breaker Discussion: The EMPULSE Trial Harriette Van Spall, Adriaan A Voors
-
16m 2sPart 1 | Session 2 AHA 21 Late-breaker Discussion: The CHIEF-HF Clinical Trial John Spertus, Harriette Van Spall
-
12m 12sPart 1 | Session 3 AHA 2021 Late-breaker Discussion: The Digital Care Transformation Study Alexander J Blood, Harriette Van Spall
-
9m 51sPart 2 View from the Thoraxcenter – What's Hot at AHA 2021 Nicolas M Van Mieghem, Joost Daemen
-
5m 28sPart 3 | Session 1 Population Strategies for the Management of Hypertension Anushka Patel
-
5m 41sPart 3 | Session 2 ROSE: CETPi Lowers LDL-C in Patients Taking High Intensity Statins Stephen Nicholls
-
7m 58sPart 3 | Session 3 AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of Venous Thromboembolism Jeffrey Weitz
-
6m 56sPart 3 | Session 4 EAST-AFNET 4: Early Rhythm Control Was Consistent in AF Patterns Andreas Goette
-
6m 35sPart 3 | Session 5 EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFp Javed Butler
-
10m 20sPart 3 | Session 6 AHA 2021: Evaluating the Benefit of Concomitant TV Repair During Mitral Valve Surgery James Gammie
-
4m 26sPart 3 | Session 7 SGLT2 is Associated with Reduction in Atrial-Arrythmic Events Ilan Goldenberg
-
8m 26sPart 3 | Session 8 SMART-CRT: Effects of AV Optimization on CRT Outcomes Michael R Gold
-
10m 10sPart 3 | Session 9 AVATAR: Aortic Valve Replacement Vs Watchful Waiting in Asymptomatic Severe AS Marko Banovic
-
22m 15sPart 3 | Session 10 EMPATROPISM FE: Effects of Empagliflozin on iron metabolism in non-diabetic HF patients Christiane Angermann
Overview
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen provide a concise and insightful preview of the late-breaking science presented at AHA Scientific Sessions 2021.
For a deep-dive, watch Dr Harriette Van Spall's Late-breaking Discussion series on highly expected trials with principal investigators.
Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
Late-breaker Discussion Series
Host, Dr Harriette Van Spall interviews the late-breaker presenters of AHA Scientific Sessions 2021.
Part 2
View from the Thoraxcenter: Preview of the Late-Breaking Trials
Part 3
Expert Interviews
Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.
Faculty Biographies
